In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
104 News Items found
Albert Kuchler discussing his treatment results with MSK oncologist Bob Li at a recent clinic visit.
Feature
For People with a Rare Mouth Cancer, a Targeted Drug Can Be Lifesaving

The drug targets a protein called HER2 found on some salivary gland tumors.
Kate Delp standing on the beach, smiling and holding a yoga mat
Finding
Why More People With Breast Cancer Are Choosing Lumpectomy Over Mastectomy: Kate’s Story

An MSK study found a rise in lumpectomies and a decline in mastectomies — reversing a trend that experts say was leading to the overtreatment of breast cancer.
Albert Kuchler with MSK medical oncologist Bob Li.
Harnessing the Power of Data for Patient Care

Computational biology is helping to bring predictive power and precision to oncology.
Kirt Robinson
In the Clinic
Kirt’s Story: How a Clinical Trial for a Rare Tumor Gave Me a New Lease on Life

A clinical trial led by MSK sarcoma expert Mrinal Gounder has shown promising results for treating desmoid tumors.
Clinical nurse Jenna Longo, neuroendocrinologist Eliza Geer, neurosurgeon Viviane Tabar, and head and neck surgeon Marc Cohen
In the Clinic
Masters of the Master Gland: Inside MSK’s Multidisciplinary Pituitary and Skull Base Tumor Center

Learn what sets care for pituitary tumors apart from the rest at Memorial Sloan Kettering’s Multidisciplinary Pituitary and Skull Base Tumor Center.
Memorial Sloan Kettering Cancer Center Endorses HPV Vaccination for Cancer Prevention

MSK has joined with 68 of the nation’s top cancer centers in issuing a statement urging increased HPV vaccination for the prevention of cancer. This statement, signed by MSK Physician-in-Chief and Chief Medical Officer José Baslega, MD, PhD, and colleagues at NCI-designated cancer centers across the country, calls upon the nation’s physicians, parents, and young adults to take advantage of this rare opportunity to prevent many types of cancer. MSK head and neck and gynecologic cancer experts are available to discuss the importance of the HPV vaccine and risks of HPV-related cancers. Please email [email protected] to arrange an interview.
FDA Expands Use of HPV Vaccine: What It Means in the Fight against Cancer

The US Food and Drug Administration has updated its recommendations for the use of Gardasil 9, the vaccine that protects against human papillomavirus (HPV), to include people age 27 to 45. Previously, Gardasil 9 was only approved for use in those between age nine and 26. 
Young man receiving chemotherapy.
Q&A
Meet the MSK Oncologist on a Quest to Cure Hodgkin Lymphoma with Fewer Long-Term Side Effects

MSK medical oncologist David Straus is looking for less-intensive treatments for Hodgkin lymphoma, a type of blood cancer most commonly found in young adults.
Marcia Levine
An Unplanned Path to Nursing Leadership at MSK

Marcia Levine didn’t grow up wanting to be a nurse. It’s a career that found her, providing a direction for the desire she always had to help, to fix things, to care for others.
Elaine sitting down on a mountain with her border collie between her legs
MSK Nurse Exemplifies Tradition of Filipino Nursing in America

Elaine Mosqueda has traveled far in so many ways since moving from the Philippines to the United States at the age of 21.